---
format:
  revealjs:
    css: index.css
    footer: "Jacob Widaeus - Karolinska Institute, Department of clinical sciences, Danderyd Hospital"
    incremental: false
---
# Individual study plan
**Bedside assessment of microvascular dysfunction**

method evaluation in clinical studies
<img src="images/ki-ds.png" class="logo" style="width: 400px; height: auto;">

## Disposition
- <span style="font-size:30px;">**Introduction and Background**: Introduction to the topic, research objectives</span>

- <span style="font-size:30px;">**Research plan and Methodology**: Study designs, methods and analysis</span>

- <span style="font-size:30px;">**Timeline and Milestones**: Project timeline with key milestones</span>

- <span style="font-size:30px;">**Resources and Support**: Overview of  resoruces and support</span>

- <span style="font-size:30px;">**Discussion and Feedback**: Opporunity for audience feedback</span>
<img src="images/ki-ds.png" class="logo">

---

<span style="font-size: 20px;">Introduction and Background</span>

### Relevance

<img src="images/vascular-man.jpg" style="width:35%; display: block; margin: auto;">

<img src="images/ki-ds.png" class="logo">
---

<span style="font-size: 20px;">Introduction and Background</span>

### Relevance

<img src="images/vascular-man.jpg" style="width:17%; position: absolute; top: 1px; right: 1px;">

<span style="font-size:25px;">**Key Areas**: Cardiovascular disease, diabetes, heart failure, sepsis</span>

<span class="fragment" data-fragment-index="1" style="font-size:25px;">Clinical Implications</span>
  
<span class="fragment" data-fragment-index="2" style="font-size:20px;">**Early Detection and Prevention**: Monitoring microvascular function helps identify patients at high risk, enabling early intervention and preventive measures.</span>
  
<span class="fragment" data-fragment-index="3" style="font-size:20px;">**Disease Progression and Treatment Monitoring**: Microvascular assessment provides a window into disease activity, aiding in the evaluation of treatment effectiveness.</span>
  
<span class="fragment" data-fragment-index="4" style="font-size:20px;">**Goal-directed therapy**: Insights into microvascular health support goal-directed therapies, optimizing treatment plans tailored to individual needs.</span>
<img src="images/ki-ds.png" class="logo">

---

<span style="font-size: 20px;">Introduction and Background</span>

### Problem

<div style="margin-bottom: 40px;"></div>

<span style="font-size:25px;">**Current methods**</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Capillary refill time</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Subjectivity, variability, sens/spec, non-quantifiable*</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Coronary angiography</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Invasive, cumbersome, resource intensive, organ specific</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Stress Cardiac MRT</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Cumbersome, resource intensive, organ specific</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Biomarkers</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Analysis time, interpretation, resource intensive</span>
<img src="images/ki-ds.png" class="logo">

---

<span style="font-size: 20px;">Introduction and Background</span>

### Problem

<div style="margin-bottom: 40px;"></div>

<span style="font-size:25px;">**Future methods - what is needed?**</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Quantitative</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Precision and comparison</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Non-invasive</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Risk and discomfort</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Low variability and High sensitivity</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Consistency and precision</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Rapid and ease of use</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Clinical convenience</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Organ-agnostic</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Systemic dysfunction</span>

<span class="fragment" data-fragment-index="1" style="display:inline-block; width:400px; font-size:25px; white-space: nowrap;">Cost-effective</span>
<span class="fragment" data-fragment-index="2" style="font-size:25px;">Iterative usage and goal-directed</span>
<img src="images/ki-ds.png" class="logo">

---

#### Research plan and Methodology


```{mermaid}
%%{init: {'theme': 'default', 'themeVariables': { 'textColor': '#798189'}}}%%
gantt
    title Big Ol' Gantts
    dateFormat  YYYY-MM-DD
    section Section
    Some Normal Tasks : done, a1, 2022-09-01, 15d
    But Wait, There's More! : after a1, 20d
    section And ANOTHER
    Deary Me, It's Never Ending : crit, 2022-10-01, 20d
    I Hate This Project : 2022-10-21, 14d
```
.
<img src="images/ki-ds.png" class="logo">

---

#### Timeline and Milestones

- **Partnerships**: How collaboration fosters innovation.
<img src="images/ki-ds.png" class="logo">

---

#### Resources and Support

- **Summary**: Key points discussed.
<img src="images/ki-ds.png" class="logo">

---

#### Challanges and Risk Management

- **Many challanges wow**
<img src="images/ki-ds.png" class="logo">

---

#### Discussion and Feedback

- **So much feedback!**
<img src="images/ki-ds.png" class="logo">

----